View in EDS

Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Saved in:
Bibliographic Details
Title: Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Authors: Runaas L; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Fank S; Cancer Center Clinical Trials Office, Medical College of Wisconsin, Milwaukee, WI., Palen K; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Szabo A; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI., Rein LE; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI., Ying G; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Salzman N; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Samanas L; Froedtert Pharmacy, Froedtert Hospital, Milwaukee, WI., Abedin S; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Chhabra S; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Hamadani M; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Longo W; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Shah NN; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Haber J; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY., Gradissimo A; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY., Waters N; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY., Peled JU; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY., Johnson B; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Kearl T; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Drobyski WR; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Source: Blood advances [Blood Adv] 2026 Apr 28; Vol. 10 (8), pp. 2698-2710.
Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41632629
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Runaas+L%22">Runaas L</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Fank+S%22">Fank S</searchLink>; Cancer Center Clinical Trials Office, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Palen+K%22">Palen K</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Szabo+A%22">Szabo A</searchLink>; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Rein+LE%22">Rein LE</searchLink>; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Ying+G%22">Ying G</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Salzman+N%22">Salzman N</searchLink>; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Samanas+L%22">Samanas L</searchLink>; Froedtert Pharmacy, Froedtert Hospital, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Abedin+S%22">Abedin S</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Chhabra+S%22">Chhabra S</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Hamadani+M%22">Hamadani M</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Longo+W%22">Longo W</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Shah+NN%22">Shah NN</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Haber+J%22">Haber J</searchLink>; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.<br /><searchLink fieldCode="AU" term="%22Gradissimo+A%22">Gradissimo A</searchLink>; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.<br /><searchLink fieldCode="AU" term="%22Waters+N%22">Waters N</searchLink>; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.<br /><searchLink fieldCode="AU" term="%22Peled+JU%22">Peled JU</searchLink>; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.<br /><searchLink fieldCode="AU" term="%22Johnson+B%22">Johnson B</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Kearl+T%22">Kearl T</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.<br /><searchLink fieldCode="AU" term="%22Drobyski+WR%22">Drobyski WR</searchLink>; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Apr 28; Vol. 10 (8), pp. 2698-2710.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41632629
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025019065
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2698
    Titles:
      – TitleFull: Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Runaas L
      – PersonEntity:
          Name:
            NameFull: Fank S
      – PersonEntity:
          Name:
            NameFull: Palen K
      – PersonEntity:
          Name:
            NameFull: Szabo A
      – PersonEntity:
          Name:
            NameFull: Rein LE
      – PersonEntity:
          Name:
            NameFull: Ying G
      – PersonEntity:
          Name:
            NameFull: Salzman N
      – PersonEntity:
          Name:
            NameFull: Samanas L
      – PersonEntity:
          Name:
            NameFull: Abedin S
      – PersonEntity:
          Name:
            NameFull: Chhabra S
      – PersonEntity:
          Name:
            NameFull: Hamadani M
      – PersonEntity:
          Name:
            NameFull: Longo W
      – PersonEntity:
          Name:
            NameFull: Shah NN
      – PersonEntity:
          Name:
            NameFull: Haber J
      – PersonEntity:
          Name:
            NameFull: Gradissimo A
      – PersonEntity:
          Name:
            NameFull: Waters N
      – PersonEntity:
          Name:
            NameFull: Peled JU
      – PersonEntity:
          Name:
            NameFull: Johnson B
      – PersonEntity:
          Name:
            NameFull: Kearl T
      – PersonEntity:
          Name:
            NameFull: Drobyski WR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 04
              Text: 2026 Apr 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1